BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 22051859)

  • 21. Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero.
    Ajaykumar A; Zhu M; Kakkar F; Brophy J; Bitnun A; Alimenti A; Soudeyns H; Saberi S; Albert AYK; Money DM; Côté HCF;
    J Infect Dis; 2021 Feb; 223(4):621-631. PubMed ID: 32638023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?
    Thorne C; Newell ML
    Drug Saf; 2007; 30(3):203-13. PubMed ID: 17343429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brief Report: High Sensitivity and Specificity of the Cepheid Xpert HIV-1 Qualitative Point-of-Care Test Among Newborns in Botswana.
    Ibrahim M; Moyo S; Mohammed T; Mupfumi L; Gaseitsiwe S; Maswabi K; Ajibola G; Gelman R; Batlang O; Sakoi M; Auletta-Young C; Makhema J; Lockman S; Shapiro RL
    J Acquir Immune Defic Syndr; 2017 Aug; 75(5):e128-e131. PubMed ID: 28350554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
    le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L
    Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission.
    Briand N; Le Coeur S; Traisathit P; Karnchanamayul V; Hansudewechakul R; Ngampiyasakul C; Bhakeecheep S; Ithisukanan J; Hongsiriwon S; McIntosh K; Lallemant M
    Pediatr Infect Dis J; 2006 Apr; 25(4):325-32. PubMed ID: 16567984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
    Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG
    Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An unusual case of hyperlactataemia in a neonate.
    Nirupam N; Nangia S; Kumar A; Saili A
    Int J STD AIDS; 2013 Dec; 24(12):986-8. PubMed ID: 23970612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morbidity and mortality during the first two years of life among uninfected children born to human immunodeficiency virus type 1-infected women: the women and infants transmission study.
    Paul ME; Chantry CJ; Read JS; Frederick MM; Lu M; Pitt J; Turpin DB; Cooper ER; Handelsman EL
    Pediatr Infect Dis J; 2005 Jan; 24(1):46-56. PubMed ID: 15665710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
    Thorne C; Newell ML
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.
    Brogly SB; Ylitalo N; Mofenson LM; Oleske J; Van Dyke R; Crain MJ; Abzug MJ; Brady M; Jean-Philippe P; Hughes MD; Seage GR
    AIDS; 2007 May; 21(8):929-38. PubMed ID: 17457086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukocyte Telomere Length at Birth and During the Early Life of Children Exposed to but Uninfected With HIV After In Utero Exposure to Antiretrovirals.
    Ajaykumar A; Soudeyns H; Kakkar F; Brophy J; Bitnun A; Alimenti A; Albert AYK; Money DM; Côté HCF; ;
    J Infect Dis; 2018 Feb; 217(5):710-720. PubMed ID: 29228317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia.
    Okawa S; Chirwa M; Ishikawa N; Kapyata H; Msiska CY; Syakantu G; Miyano S; Komada K; Jimba M; Yasuoka J
    BMC Pregnancy Childbirth; 2015 Oct; 15():258. PubMed ID: 26459335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Effects of In Utero Antiretroviral Exposure: Systolic and Diastolic Function in HIV-Exposed Uninfected Youth.
    Guerra V; Leister EC; Williams PL; Starc TJ; Lipshultz SE; Wilkinson JD; Van Dyke RB; Hazra R; Colan SD
    AIDS Res Hum Retroviruses; 2016 Jul; 32(7):621-7. PubMed ID: 26794032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals.
    Noguera A; Fortuny C; Muñoz-Almagro C; Sanchez E; Vilaseca MA; Artuch R; Pou J; Jimenez R
    Pediatrics; 2004 Nov; 114(5):e598-603. PubMed ID: 15492359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of definitive severe mitochondrial signs and symptoms among deceased HIV-uninfected and HIV-indeterminate children < or = 5 years of age, Pediatric Spectrum of HIV Disease project (PSD), USA.
    Dominguez K; Bertolli J; Fowler M; Peters V; Ortiz I; Melville S; Rakusan T; Frederick T; Hsu H; D'Almada P; Maldonado Y; Wilfert C;
    Ann N Y Acad Sci; 2000 Nov; 918():236-46. PubMed ID: 11131710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies against pneumococcal capsular polysaccharide in Malawian HIV-positive mothers and their HIV-exposed uninfected children.
    Baroncelli S; Galluzzo CM; Mancinelli S; Andreotti M; Jere H; Amici R; Marazzi MC; Vella S; Palombi L; Giuliano M
    Infect Dis (Lond); 2016 Apr; 48(4):317-321. PubMed ID: 26609569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Birth prevalence of congenital cytomegalovirus among infants of HIV-infected women on prenatal antiretroviral prophylaxis in South Africa.
    Manicklal S; van Niekerk AM; Kroon SM; Hutto C; Novak Z; Pati SK; Chowdhury N; Hsiao NY; Boppana SB
    Clin Infect Dis; 2014 May; 58(10):1467-72. PubMed ID: 24567248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National-level effectiveness of ART to prevent early mother to child transmission of HIV in Namibia.
    Agabu A; Baughman AL; Fischer-Walker C; de Klerk M; Mutenda N; Rusberg F; Diergaardt D; Pentikainen N; Sawadogo S; Agolory S; Dinh TH
    PLoS One; 2020; 15(11):e0233341. PubMed ID: 33170840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination antiretroviral use and preterm birth.
    Watts DH; Williams PL; Kacanek D; Griner R; Rich K; Hazra R; Mofenson LM; Mendez HA;
    J Infect Dis; 2013 Feb; 207(4):612-21. PubMed ID: 23204173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.